TNC and achalasia-alacrima syndrome: TN-C contributes in stratifying risk in patients with AAA before intervention or after EVAR [2], but further study is required to elucidate the function of TN-C and to evaluate whether serum levels or bioimaging of TN-C would be suited for the assessment of disease activity in human AAAs.